Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?
暂无分享,去创建一个
[1] R A Rosati,et al. The way of the future. , 1973, Archives of internal medicine.
[2] Suzy A. Buckovich,et al. Viewpoint: Driving Toward Guiding Principles: A Goal for Privacy, Confidentiality, and Security of Health Information , 1999, J. Am. Medical Informatics Assoc..
[3] C. Granger. Genetics of coronary heart disease: current understanding and future prospects. , 2000, American heart journal.
[4] L. Kohn,et al. COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .
[5] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[6] Alastair Baker,et al. Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.
[7] R. Califf,et al. Monitoring and ensuring safety during clinical research. , 2001, JAMA.
[8] William Hersh,et al. The way of the future? , 2001, Nature.
[9] Robert M Califf,et al. Integrating quality into the cycle of therapeutic development. , 2002, Journal of the American College of Cardiology.
[10] D. DeMets,et al. Principles From Clinical Trials Relevant to Clinical Practice: Part II , 2002, Circulation.
[11] Robert M Califf,et al. Lessons learned from recent cardiovascular clinical trials: Part II. , 2002, Circulation.
[12] D. DeMets,et al. Principles from clinical trials relevant to clinical practice: Part I. , 2002, Circulation.
[13] Robert M Califf,et al. Lessons learned from recent cardiovascular clinical trials: Part I. , 2002, Circulation.
[14] G. Annas. HIPAA regulations - a new era of medical-record privacy? , 2003, The New England journal of medicine.
[15] C. Deangelis. NIH Director Elias A. Zerhouni, MD, Reflects on Agency's Challenges, Priorities , 2003 .
[16] S. Goodman,et al. Toward protecting the safety of participants in clinical trials. , 2003, Controlled clinical trials.
[17] P. Kilbridge,et al. The cost of HIPAA compliance. , 2003, The New England journal of medicine.
[18] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[19] Eric L Eisenstein,et al. Reducing the costs of phase III cardiovascular clinical trials. , 2005, American heart journal.